𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Menogaril in the treatment of malignant mesothelioma: A phase II study

✍ Scribed by C. A. Hudis; D. P. Kelsen

Publisher
Springer US
Year
1992
Tongue
English
Weight
275 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of gemcitabine in patie
A phase II study of gemcitabine in patients with malignant pleural mesothelioma
✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo

Phase II study of weekly intravenous men
Phase II study of weekly intravenous menogaril in the treatment of recurrent astrocytomas in adults
✍ David J. Stewart; Herman Hugenholtz; Vasco F. DaSilva; Brian G. Benoit; Michael πŸ“‚ Article πŸ“… 1992 πŸ› Springer US 🌐 English βš– 435 KB

Twenty patients with astrocytomas recurrent after surgery + radiation were treated on a phase II protocol of the new anthracycline derivative menogaril 115 mg/m 2 administered intravenously once per week. Sixteen patients were evaluable for treatment efficacy. No patient achieved a major therapeutic